Assignee
MEMORY PHARM CORP
US·34 granted patents·18 pending applications·304 citations·filing 2000–2013
Top patents by PatentIndex Score
52 records- 0197US7902217B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2008·Granted Mar 8, 2011·86 cites·14 claims
- 0292US7696229B2Compounds having 5-HT6 receptor affinityMEMORY PHARM CORP·Filed 2007·Granted Apr 13, 2010·22 cites·30 claims
- 0387US7655802B2Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsMEMORY PHARM CORP·Filed 2006·Granted Feb 2, 2010·9 cites·35 claims
- 0487US6699890B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 2, 2004·21 cites·75 claims
- 0586US7396833B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2004·Granted Jul 8, 2008·20 cites·44 claims
- 0686US7226930B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Jun 5, 2007·27 cites·37 claims
- 0785US7087625B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Aug 8, 2006·24 cites·84 claims
- 0884US7358057B2QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cellsMEMORY PHARM CORP·Filed 2003·Granted Apr 15, 2008·14 cites·35 claims
- 0982US7625924B2Nicotinic alpha-7 receptor ligands and preparation and uses thereofMEMORY PHARM CORP·Filed 2005·Granted Dec 1, 2009·5 cites·34 claims
- 1082US7429664B2Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2003·Granted Sep 30, 2008·11 cites·42 claims
- 1181US7700631B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2006·Granted Apr 20, 2010·5 cites·19 claims
- 1279US7153871B2Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsMEMORY PHARM CORP·Filed 2003·Granted Dec 26, 2006·9 cites·40 claims
- 1377US7244745B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2003·Granted Jul 17, 2007·8 cites·69 claims
- 1476US8691841B2Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereofMEMORY PHARM CORP·Filed 2013·Granted Apr 8, 2014·2 cites·28 claims
- 1576US7943773B2Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2009·Granted May 17, 2011·1 cites·14 claims
- 1676US7632831B21H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereofMEMORY PHARM CORP·Filed 2005·Granted Dec 15, 2009·2 cites·43 claims
- 1775US7723348B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2008·Granted May 25, 2010·2 cites·61 claims
- 1875US7585882B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Sep 8, 2009·2 cites·35 claims
- 1975US7495017B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2007·Granted Feb 24, 2009·2 cites·45 claims
- 2074US7235579B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Jun 26, 2007·8 cites·48 claims
- 2172US7576080B2Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Aug 18, 2009·2 cites·43 claims
- 2271US7432266B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Oct 7, 2008·1 cites·57 claims
- 2370US7405230B2Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogsMEMORY PHARM CORP·Filed 2003·Granted Jul 29, 2008·5 cites·39 claims
- 2468US7332486B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Feb 19, 2008·3 cites·33 claims
- 2566US6656717B1Cyclic AMP phosphodiesterase isoforms and methods of useMEMORY PHARM CORP·Filed 2000·Granted Dec 2, 2003·10 cites·10 claims
- 2664US7790722B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2008·Granted Sep 7, 2010·0 cites·19 claims
- 2761US7696198B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 13, 2010·1 cites·17 claims
- 2859US7700630B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2007·Granted Apr 20, 2010·0 cites·33 claims
- 2959US2009069361A1Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylateMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 3058US7205320B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 17, 2007·2 cites·71 claims
- 3156US2010010017A1Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitorsMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3254US7335654B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Feb 26, 2008·0 cites·62 claims
- 3353US7964600B2Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereofMEMORY PHARM CORP·Filed 2010·Granted Jun 21, 2011·0 cites·33 claims
- 3453US2010056491A14'-amino cyclic compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3552US2010029689A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3652US2010022581A1Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3752US2010056531A1Alkyl-substituted 3' compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3851US7342021B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 11, 2008·0 cites·68 claims
- 3951US2010029629A1Acyclic compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 4051US2010016297A1Alkyl-substituted 3' compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 4151US2006166316A1Phosphodiesterase 10a7 isoforms and methods of useMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
- 4250US2009069337A13' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4350US2010298306A1(1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of DiseaseMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4449US7994199B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2010·Granted Aug 9, 2011·0 cites·14 claims
- 4549US2008318941A14' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4649US2008200471A16' substituted compounds having 5-ht6 receptor affinityMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 4747US2003149052A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Application pending·0 cites
- 4846US2006168668A1Phosphodiesterase 2a and methods of useMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
- 4945US7932248B21H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereofMEMORY PHARM CORP·Filed 2006·Granted Apr 26, 2011·0 cites·23 claims
- 5045US2006142188A1Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereofMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →